progression-free survival
Complete response rate after chemotherapy was 83.8% (95% CI, 71.1-96.5%), progression-free survival (PFS) rate at 12-month was 82.5%, 2-year PFS was 78.7%; overall survival (OS) rate at 12- month was 82.3%, 2-year OS was 82.3%.
Complete response rate after chemotherapy was 83 .8% ( 95% CI, 71 .1-96 .5% ), progression-free survival ( PFS ) rate at 12-month was 82 .5%, 2-year PFS was 78 .7%; overall survival ( OS ) rate at 12- month was 82 .3%, 2-year OS was 82 .3% .